ProShares UltraPro Nasdaq Biotechnology (UBIO)

Add to Watchlists
Create an Alert
24.04 -1.38  -5.43% NASDAQ Dec 14, 20:00 Delayed 2m USD
View Full Chart
UBIO Price Chart
View All UBIO News

UBIO News

UBIO Performance

  Total Return (Price) Total Return (NAV) Cat. Total Return (NAV) % Rank in Cat. (NAV)
1M -1.80% -2.12% -- --
3M -39.98% -40.05% -- --
6M -30.80% -31.19% -- --
YTD -28.54% -28.72% -- --
1Y -25.18% -25.30% -- --
3Y -21.45% -21.51% -- --
5Y -- -- -- --
10Y -- -- -- --
15Y -- -- -- --
20Y -- -- -- --
As of Dec. 14, 2018. Returns for periods of 1 year and above are annualized.

UBIO Asset Allocation

Type % Net % Long % Short
Cash -199.8% 23.26% 223.0%
Stock 76.74% 76.74% 0.00%
Bond 0.00% 0.00% 0.00%
Convertible 0.00% 0.00% 0.00%
Preferred 0.00% 0.00% 0.00%
Other 223.0% 223.0% 0.00%
As of Nov. 30, 2018
View More Holdings

UBIO Top 10 Holdings

Symbol Name % Weight Price % Chg
-- Nasdaq Biotechnology Index Swap Ubs Ag 137.1% -- --
-- Nasdaq Biotechnology Index Swap Bank Of America Na 37.28% -- --
-- Nasdaq Biotechnology Index Swap Goldman Sachs International 25.55% -- --
-- Nasdaq Biotechnology Index Swap Societe Generale 23.07% -- --
AMGN Amgen Inc 7.15% 192.07 -2.76%
GILD Gilead Sciences Inc 6.51% 65.57 -2.64%
BIIB Biogen Inc 6.47% 314.55 -1.75%
CELG Celgene Corp 5.02% 68.20 -2.21%
ILMN Illumina Inc 4.91% 326.46 -2.44%
VRTX Vertex Pharmaceuticals Inc 3.36% 170.06 -1.94%
As of Nov. 30, 2018
Advertisement

UBIO Basic Info

Style
Equity Style Large Cap/Growth
Broad Asset Class Alternative
Broad Category Alternative
Category Name Trading--Leveraged Equity
Prospectus Objective Specialty - Technology
Fund Owner Firm Name ProShares
Benchmark Index
NASDAQ Biotechnology TR USD
300.0%

UBIO Manager Info

Name Tenure
Michael Neches 3.36 yrs
Tarak Davé 0.51 yrs

UBIO Net Fund Flows

1M 4.455M
3M 7.545M
6M -4.997M
YTD -14.09M
1Y -19.12M
3Y -10.50M
5Y --
10Y --
As of Nov. 30, 2018

UBIO Risk Info

Beta (5Y) 4.366
Max Drawdown (All) 84.16%
Historical Sharpe (10Y) --
Historical Sortino (All) -0.1426
30-Day Rolling Volatility 86.23%
Daily Value at Risk (VaR) 1% (All) 12.29%
Monthly Value at Risk (VaR) 1% (All) 47.53%

UBIO Comparables

Edit

UBIO Attributes

Key Dates
Inception Date 6/22/2015
Termination Date
Last Annual Report Date 5/31/2018
Last Prospectus Date 6/12/2018
Attributes
Exchange Traded Share Yes
Exchange Traded Note No
Enhanced Index Fund No
Fixed Distribution Fund No
High-Net Worth Individual Fund No
Index Fund Yes
Inverse Fund No
Leveraged Fund Yes
Fund of Funds No
Currency Hedged Fund No
Synthetic Replication Fund No
Has Dividend Investment Plan No
Socially Responsible Fund No
General Availability
Available for Insurance Product No
Available for Retirement Plan No
Available for RRSP No

UBIO Excel Add-In Codes

  • Name: =YCI("UBIO","name")
  • Broad Asset Class: =YCI("UBIO", "broad_asset_class")
  • Broad Category: =YCI("UBIO", "broad_category_group")
  • Prospectus Objective: =YCI("UBIO", "prospectus_objective")

To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.

Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.

Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.